The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses
This study establishes soluble recombinant α-DGN as a broad-band, natural compound candidate therapeutic against enveloped viruses.PMID:38387750 | DOI:10.1016/j.antiviral.2024.105837
Source: Cell Research - Category: Cytology Authors: Maria Giulia Bigotti Katja Klein Esther S Gan Maria Anastasina Simon Andersson Olli Vapalahti Pekka Katajisto Maximilian Erdmann Andrew D Davidson Sarah J Butcher Ian Collinson Eng Eong Ooi Giuseppe Balistreri Andrea Brancaccio Yohei Yamauchi Source Type: research
More News: Adenoviruses | COVID-19 | Cytology | Dengue Fever | Encephalitis | Epidemics | Epidemiology | Flu Pandemic | Gastroenteritis | Influenza | Pandemics | Respiratory Medicine | SARS | Study | Tickborne Diseases